Home » General World News » Takeda is buying Adderall maker Shire for $64 billion in pharma’s biggest deal of the year

Takeda is buying Adderall maker Shire for $64 billion in pharma’s biggest deal of the year





Shire CEO Flemming Ornskov

  • Takeda has reached a deal to buy Adderall drugmaker Shire for $64.3 billion.
  • The deal comes after a handful of rejections from Shire and a short-lived potential for a bidding war between Takeda and Botox-maker Allergan.
  • A transaction between Shire and Takeda is the largest pharma deal of the year.

Takeda has reached a preliminary agreement to buy Adderall drugmaker Shire for $64 billion in the largest pharma deal of the year.

The deal strengthens the Japanese drugmakers’ footprint in the US, where Shire has a large presence, and also expands its position in rare diseases like hemophilia.

Takeda, read more >>>

Source:: BusinessInsider.Com

Comments are closed.